陳威君 主治醫師
陳威君 主治醫師林口長庚/土城醫院
婦科腫瘤 助理教授級主治醫師
  • 現任

    • 林口長庚醫院 婦產部 婦科腫瘤 助理教授級主治醫師

    • 土城醫院(委託長庚經營) 婦產部 婦科腫瘤 助理教授 主治醫師

    • 桃園長庚醫院 海扶治療中心 助理教授級主治醫師

    • 長庚紀念醫院 助理教授級主治醫師

    • 台灣婦科腫瘤消融醫學會理事

    • 精準醫學會專科醫師

    • 婦癌醫學會准會員

  • 專長

    • 海扶刀子宮肌瘤/腺瘤無傷口無創手術

    • 子宮肌瘤 肌腺症 射頻消融手術

    • 腹腔鏡微無創手術

    • 子宮肌瘤/子宮腺瘤/子宮肌腺症保留子宮諮詢
    • 婦科腫瘤微創手術:腹腔鏡、達文西機器手臂微創手術手術(子宮肌瘤、腺瘤、肌腺症、子宮內膜異位症、巧克力囊腫、卵巢囊腫手術、沾黏分離手術)
    • 瘜肉手術、子宮腔鏡手術

    • 婦科腫瘤癌症/癌前病變/陰道鏡(子宮頸癌、子宮內膜癌症、卵巢癌)手術、婦科癌症腹腔熱化學治療
    • 國際醫療(海扶刀子宮肌瘤、肌腺症消融手術、婦科腫瘤微創手術、婦科癌症治療)

 

選擇陳威君醫師的理由

認識陳醫師

精湛醫術

  • 陳醫師現為桃園院區海扶刀治療中心的成員,建立桃園長庚海扶刀中心的操作規範與常規指引。

  • 2021年參與桃園院區海扶刀中心的防疫規劃,替患者的治療安全做把關。

  • 陳醫師接受國際醫療諮詢就醫,有來自中國、香港、美國、及法國及新加坡等子宮肌瘤、肌腺症、婦科腫瘤、婦科癌症、海扶刀及微創手術等豐富治療經驗。

  • 參與癌症病友的講座介紹腹腔內熱化學治療於卵巢癌的應用

  • 105年至美國參與熱化療專家Sugarbaker腹膜腫瘤醫學會(PSOGI)研討會,專注腹腔內溫熱化療,希望讓患者接受新式治療之餘,也能有安全及生活品質的改善。

認識陳醫師

親切友善

  • 陳醫師凡事親力親為,親切友善溝通與您建立良好的醫病關係,讓您感受到溫暖,用心照顧女性朋友的健康。

  • 喜歡將醫學知識及衛教、經驗,藉由文章以分享專業,讓女性朋友更了解婦科及婦癌相關知識。

  • 陳醫師廣受病患口碑好評,持續為患者提供有溫度的服務。

認識陳醫師

科學數據

  • 專注於婦科腫瘤及婦科癌症研究,多次參與院內整合型計畫,擔任臨床試驗主持人,制定子宮頸癌醫病共享決策(SDM)的決策範本。

  •  參與婦癌團隊,協助婦癌診療指引修訂。

  • 2021年參與台灣婦癌研究組織( TGOG)的法人化成立,成為會員,並參與跨國跨院子宮內膜癌臨床試驗,期待為病人爭取更多治療機會。

  • 自 2020 年起與清華大學生物醫學工程所合作,持續在婦科腫瘤與癌症領域專精。

  • 2021年度以一作者榮獲優秀論文。

認識陳醫師

用心團隊

  • JCI 認證全球最大醫學中心級醫院,醫療儀器設備齊全,國際病患新選擇 。

  • 長庚海扶治療中心營造溫馨舒適的環境,讓您在治療中,心情是放鬆且愉快,增進您與醫護人員間的瞭解、信任感,共創造最佳醫療品質。

  • 專業的海扶醫療團隊,陳醫師精準在術前判斷腫瘤的良性與惡性,針對子宮肌瘤、子宮腺肌症開展高強度聚焦超聲消融治療;專業麻醉團隊,隨時監控患者反應,達到舒適且安全目標。

認識陳醫師

免開刀 無傷口 海扶刀治療影片

陳威君醫師醫學論文書籍著作

獲獎紀錄:
  • 榮獲徐千田防癌研究基金會優秀論文獎第二名
  • 論文「Prediction of myometrial invasion in stage I endometrial cancer by MRI: the influence of surgical diagnostic procedure」刊登在Cancers期刊上,獲得基隆長庚院區優秀論文
論文發表:
  • (01)Chen WC#, Qiu JT#, Huang HJ, Lin CT, Chen MY, Lai CH*, et al. Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan. PLoS One 2017;12:e0175703. https://doi.org/10.1371/journal.pone.0175703 (26/73=34.93%) (published online 3 May 2017; SCI impact factor: 3.240) (First author with equal contribution#)
  • (02)Chen WC, Huang HJ, Chang TC, Chou HH*. Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer. Taiwan J Obstet Gynecol 2020;59(1):21-7. https://doi.org/10.1016/j.tjog.2019.10.003 (72/83=86.14%) (published online in Jan 2020; SCI impact factor: 1.705) (First author)
  • (03)Huang HJ, Tung HJ, Yang LY, Ku FC, Chao A, Tang YH, Chou HH, Chang WY, Wu RC, Huang CC, Chen WC, Lin CT, Huang KG, Wang CJ, Chang TC, Lai CH*. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.Int J Cancer 2020; 1–8. https://doi.org/10.1002/ijc.33251 (42/242=17.15%) (published online 1 Sep 2020; SCI impact factor: 7.396) (coauthor)
  • (04)Chou HH, Chen WC, Yan LY, Huang HJ, Chan WY, Lin H, Wu RC, Chen MY, Qiu JT, Huang KG, Chao A, Chang TC, Lai CH*. Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial. Eur J Obstet Gynecol Reprod Biol. 2021 Apr 18;262:13-20. https://doi.org/10.1016/j.ejogrb.2021.04.017 (49/83=58.43%) (published on line 18 Apr 2021; SCI impact factor: 2.435) (Coauthor)
  • (05)Lin CY, Tsai CL, Chao A, Lee LY, Chen WC, Tang YH, Chao AS, Lai CH*. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression. J Mol Med (Berl). 2021 May 5. https://doi.org/10.1007/s00109-021-02079-x (48/175=27.14%) (published on line 5 May 2021; SCI impact factor: 4.599) (Coauthor)
  • (06)Chang SH, Chang TC, Chen MY, Chen WC, Chou HH*. Comparison of the Efficacy and Safety of Dinalbuphine Sebacate, Patient-Controlled Analgesia, and Conventional Analgesia After Laparotomy for Gynecologic Cancers: A Retrospective Study.Journal of Pain Research. 2021 Jun 15; 2021:14:1763-1711. https://doi.org/10.2147/JPR.S314304 (114/208=54.57%) (published on line 15 Jun 2021; SCI impact factor: 3.133) (Coauthor)
  • (07)Chen WC, Hsu LT, Huang YT, Pan YB, Ueng SH, Chou HH*, Chang TC*. Prediction of myometrial invasion in stage 1 endometrial cancer by MRI: The influence of surgical diagnostic procedure. Cancers. 2021 Jun 30; 2021:13(13), 3275. https://doi.org/10.3390/cancers13133275 (51/242=20.87%) (published on line 30 Jun 2021; SCI impact factor: 6.639) (First author)
  • (08)Cheng WJ, Chiang CC, Peng MT, Huang YT, Huang JL, Chang SH, Yang HT, Chen WC, Kuo JJ, Hwang TL*. Chronic Obstructive Pulmonary Disease Increases the Risk of Mortality among Patients with Colorectal Cancer: A Nationwide Population-Based Retrospective Cohort Study. Int J Environ Res Public Health. 2021 Aug 19;18(16):8742.https://doi.org/10.3390/ijerph18168742. (42/176=23.86%)(published on line 19 Aug. 2021; SCI impact factor: 3.390) (Coauthor)
  • (09)Lin YP, Chen WC, Cheng CM, Shen CJ*. Vaginal pH Value for Clinical Diagnosis and Treatment of Common Vaginitis. Diagnostics2021, 11(11), 1996.https://doi.org/10.3390/diagnostics11111996. (45/167=26.95%)(published on line 27 Oct. 2021; SCI impact factor: 3.706) (Coauthor)
  • (10)Chen WC, Huang HJ, Yang LY, Pan YB, Huang KG, Lin CT, Chen MY, Tang YH, Chang TC, Lai CH, Chou HH*. Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer. Biomedical Journal 2021 Oct 14;S2319-4170(21)00137-2. https://doi.org/10.1016/j.bj.2021.10.003. (52/140=37.14%)(SCI impact factor: 4.910)(First author)
  • (11)Chen WC#, Chang TC, Chou HH*. Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy. Biomedical Journal 2022 Jan 19;S2319-4170(22)00022-1. https://doi.org/10.1016/j.bj.2022.01.012. (52/140=37.14%)(SCI impact factor: 4.910)(Letter to editors)(First author)
  • (12)Chen WC#, Cheng CM, Liao WT, Chang TC*. Urinary Biomarkers for Detection of Clinical Endometriosis or Adenomyosis. Biomedicines 2022 Apr 1;10(4):833. DOI: https://doi.org/10.3390/biomedicines10040833. (33/276=11.95%) (published online in 1st April 2022; SCI impact factor: 6.081)(First author)
  • (13)Chen WC#, Ngan HY#, Yan LY#, Chang WY, Wu RC, Chen CY, Lin H, Cheng YM, Kan YY, Tseng CJ, Chang CC, Jung SM, Tung HJ, Tang YH, Lin CT, Chao A, Lai CH*. Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study. Taiwan J Obstet Gynecol 2022 May; 61(3):494-500. DOI: https://doi.org/10.1016/j.tjog.2022.03.036. (72/83=86.14%) (published online in May 2022; SCI impact factor: 1.705)(First author with equal contribution#)
受邀演講:
2021
  • October 31,2021, 台灣婦科海扶治療醫學會 Letrozole of HIFU Treatment of myoma
  • October 17, 2021, 中華民國醫用超音波學會 The HIFU Treatment of Leiomyoma and Adenomyosis 海扶刀:超音波治療婦科腫瘤
  • August 26, 2021, 2021 APAGE-ISMIVS HIFU Webinars-Episode 2 Video Presentation | Dr. Wei-Chun Chen-HIFU Treatment for Adenomyosis & Myoma Uterine
2020
  • September 26,2020, 台灣婦科海扶治療醫學會年會暨學術研討會,演講主題:長庚醫院治療經驗分享Application of Leuprolide in HIFU
2019
  • October 26,「2019臺北腫瘤熱療國際研討會」講者Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer
  • October 10 – 12, 2019, The 6th Biennial Meeting of Asian Society of Gynecologic Oncology, 2019ASGO Acceptance Notice for Oral Presentation:Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer
  • July 21, 2019, 台灣中醫藥品質醫學會 經痛、不孕症與子宮肌腺症中西醫最新療法學術講座,演講主題:婦科腫瘤之超音波及核磁共振影像判讀 海扶刀技術原理與發展沿革與治療子宮腫瘤經驗分享
  • April 28, 2019, 台灣婦科海扶治療醫學會年會暨學術研討會,演講主題:長庚醫院治療經驗分享HIFU in Linkou Chang Gung Memorial Hospital
2018
  • April 28, 2018, 台灣精準醫學會:卵巢癌硏討會卵巢癌的化療(含 HIPEC 熱化療)
  • March 17, 2018, 台灣婦產科醫學會年會暨擴大學術研討會論文發表:腹腔熱化療於卵巢癌的應用: 單一醫學中心的經驗Hyperthermic intraperitoneal chemotherapy in gynecologic cancer: the experience in one tertiary hospital of northern Taiwan
  • February 23, 2018台灣婦癌醫學會Should patients go to ICU after HIPEC? Response and complications of HIPEC in recurrent ovarian cancer
2017
  • August 29, 2017, 林口長庚醫院婦癌病友座談會手術中之高溫熱化學治療之介紹
  • March 18, 2017, 台灣婦產科醫學會國際學術交流Intraperitoneal administration of Bevacizumab for management of malignant ascites of epithelial ovarian cancer: experience in a tertiary care hospital of northern Taiwan
擔任林口長庚醫院護理部『專科護理師培育訓練』課程講師
  • November 23, 2021, 擔任2021年度林口長庚醫院護理部『專科護理師培育訓練』課程講師 題目:婦女疾病之病生理、評估診斷與處置
  • August 13, 2020, 擔任2020年度林口長庚醫院護理部『專科護理師培育訓練』課程講師題目:婦女疾病之病生理、評估診斷與處置
書籍雜誌採訪:

線上諮詢

若您無法使用LINE@,歡迎您利用這,填寫線上諮詢單,
陳威君醫師會回信給您!